TY - JOUR
T1 - Predictors of failure after high urgent listing for a heart transplant
AU - Sunavsky, Jakub
AU - Fujita, Buntaro
AU - Ensminger, Stephan
AU - Börgermann, Jochen
AU - Morshuis, Michiel
AU - Fuchs, Uwe
AU - Oldenburg, Olaf
AU - Gummert, Jan F.
AU - Schulz, Uwe
N1 - Publisher Copyright:
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018
Y1 - 2018
N2 - OBJECTIVES: As waiting times for a heart transplant (HTx) increase, the decision of whether a patient should have a high urgent (HU) listing or mechanical circulatory support becomes crucial for further prognosis. The aim of this study was to determine the characteristics that predict failure of an HU listing (death/delisting due to urgent mechanical circulatory support implant or poor clinical condition), the 5-year survival rate, the 1-year post-transplant survival rate and the prognostic accuracy of the cardiac allocation score of patients on the HU list. METHODS: A total of 447 patients who were on the HU list at our institution between 2005 and 2016 were analysed and stratified according to occurrence of therapy failure or reception of an HTx. RESULTS: A total of 114 patients suffered from HU listing failure after a median HU time of 31.5 (15–69) days; 320 patients had a primary HTx after a median time of 51.5 (26–90) days on the HU list; 13 patients were excluded from data analysis because of an ongoing HU listing or delisting due to improvement in their haemodynamic condition. In multivariable logistic regression analysis, blood group 0 [odds ratio (OR) 2.48, 95% confidence interval (CI) 1.43–4.3; P = 0.001], INTERMACS Class 1 or 2 (OR 5.1, 95% CI 2.7–9.4; P < 0.001), vasoactive inotropic score (OR 1.18, 95% CI 1.09–1.27; P < 0.001) and brain natriuretic peptide levels (OR 1.00, 95% CI 1.00–1.00; P = 0.001) were identified as independent predictors of HU listing failure. Cardiac allocation score was not independently associated with listing failure. Estimated 5-year and 1-year post-HTx survival rates were similar in the primary HTx group and in patients receiving an HTx after HU therapy failure (P = 0.48 and P = 0.7, respectively). CONCLUSIONS: INTERMACS levels 1 and 2 and vasoactive inotropic score were the strongest predictors of HU listing failure.
AB - OBJECTIVES: As waiting times for a heart transplant (HTx) increase, the decision of whether a patient should have a high urgent (HU) listing or mechanical circulatory support becomes crucial for further prognosis. The aim of this study was to determine the characteristics that predict failure of an HU listing (death/delisting due to urgent mechanical circulatory support implant or poor clinical condition), the 5-year survival rate, the 1-year post-transplant survival rate and the prognostic accuracy of the cardiac allocation score of patients on the HU list. METHODS: A total of 447 patients who were on the HU list at our institution between 2005 and 2016 were analysed and stratified according to occurrence of therapy failure or reception of an HTx. RESULTS: A total of 114 patients suffered from HU listing failure after a median HU time of 31.5 (15–69) days; 320 patients had a primary HTx after a median time of 51.5 (26–90) days on the HU list; 13 patients were excluded from data analysis because of an ongoing HU listing or delisting due to improvement in their haemodynamic condition. In multivariable logistic regression analysis, blood group 0 [odds ratio (OR) 2.48, 95% confidence interval (CI) 1.43–4.3; P = 0.001], INTERMACS Class 1 or 2 (OR 5.1, 95% CI 2.7–9.4; P < 0.001), vasoactive inotropic score (OR 1.18, 95% CI 1.09–1.27; P < 0.001) and brain natriuretic peptide levels (OR 1.00, 95% CI 1.00–1.00; P = 0.001) were identified as independent predictors of HU listing failure. Cardiac allocation score was not independently associated with listing failure. Estimated 5-year and 1-year post-HTx survival rates were similar in the primary HTx group and in patients receiving an HTx after HU therapy failure (P = 0.48 and P = 0.7, respectively). CONCLUSIONS: INTERMACS levels 1 and 2 and vasoactive inotropic score were the strongest predictors of HU listing failure.
UR - http://www.scopus.com/inward/record.url?scp=85057566500&partnerID=8YFLogxK
U2 - 10.1093/icvts/ivy140
DO - 10.1093/icvts/ivy140
M3 - Journal articles
C2 - 30085128
AN - SCOPUS:85057566500
SN - 1569-9293
VL - 27
SP - 950
EP - 957
JO - Interactive Cardiovascular and Thoracic Surgery
JF - Interactive Cardiovascular and Thoracic Surgery
IS - 6
ER -